Clovis Oncology Stock | Climbing On Upgrade

Clovis Oncology Inc (NASDAQ: CLVS) If you’ve read my previous posts about Goldman Sachs, you know that I’m not a big fan of the company, nor their analysts. Nonetheless, everyone is talking about their most recent upgrade, and personally, I think they got it right. Earlier today, Terence Flynn, a Goldman Sachs analysts upgraded CLVS … Read more

CHANGE is COMING! | Credit Scores Man Speaks!

Change is coming and it’s positive! The Attorney General, Eric Schneiderman, from the great state of New York has been working with the credit reporting agencies on an agreement that should be good for the more than 200 million credit users in America. This agreement by the 3 major credit bureaus, Equifax, Experian, and TransUnion … Read more

MannKind (MNKD) Stock | Calls Far Out Number Puts

MannKind Corporation (NASDAQ: MNKD) MannKind Corporation has been the topic of harsh criticism lately. After an unfounded Goldman Sachs downgrade, it seems like experts have decided to bash the stock left and right; ultimately driving its value down far below where it should be. However, it seems as though investors are starting to notice the … Read more

Arrowhead Research Stock Climbs On FDA Clearance

Arrowhead Research Corp (NASDAQ: ARWR) Arrowhead Research Corp stock spiked strongly this morning following clearance from the FDA. The clearance provided from the United States Food and Drug Administration gives Arrowhead Research the OK to move forward with Phase 2b testing of ARC-520. The drug is a candidate for the treatment of chronic hepatitis B … Read more

Goals in One Word

That’s right, pick one word for your goals! Goals are something I do every day all year long. I know a lot about goals because I achieved all the important ones in my life. I know that sounds a little arrogant, but it is true. I was not my high school valedictorian nor did I … Read more


INTO THE TRADING WEEK, 13.04.15  via  YPT PREMIUM Last week was a tale of two U. S equity markets, YPT’s growth linked QNET-SHADOWLIST stocks that began a steath flight on Tuesday and roared for 3 days and the ‘BIG BLACK SHEEP’, which meandered on the 2015 flat line for those 3 days till finally making … Read more

Rosetta Genomics (ROSG) Stock | Why The Drop Isn’t A Big Deal

Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) Rosetta Genomics stock is having a rough day in the market today. However, it actually doesn’t look all that bad in my opinion. The reality is that we saw massive gains yesterday, and the drops today haven’t even come close to leveling those gains. With that said, today we’ll … Read more

Gilead Sciences (GILD) | Why Bigger Gains Are Coming

Gilead Sciences, Inc. (NASDAQ: GILD) Gilead Sciences is one of the strongest stocks in biotech, and for good reason. The company is currently the world’s leader in hepatitis C treatments as well as HIV treatments; that’s huge! However, as competitors veer into GILD’s way, they continue to innovate in order to make their treatments better. … Read more